Previously, our lab demonstrated an improvement in diastolic function and increased expression of eNOS, VEGFR2, and MAPK ERK1/ERK2 in an EV-treated MetS swine model of chronic ischemia[13,15]. Here, MAPK3 is linked to metabolic syndrome.